Microbiome Interpretation Structured microbiome reference
← Species

Ruminococcus bromii

Evidence: Moderate (associative)

Ruminococcus bromii is a keystone degrader of resistant starch in the human colon, initiating fermentation that feeds butyrate-producing partners. Many consumer panels omit or poorly detect it; low abundance often reflects diet, assay limits, or reference database gaps rather than a proven deficiency state.

What Ruminococcus bromii does in the colon

Ruminococcus bromii is a Gram-positive Firmicute specialised for resistant starch (RS), starch that escapes small-intestinal digestion and reaches the colon. In human feeding and in vitro work, R. bromii acts as a keystone primary degrader of RS granules (especially RS2 from raw potato starch and some legumes), releasing fermentation products that cross-feed butyrate producers including Roseburia and Faecalibacterium prausnitzii.

Consumer interest rose because RS interventions increase colonic butyrate in some trials and because R. bromii abundance correlates with RS response in metagenomic studies, not because every report reliably measures the species.

What reports actually resolve

FindingLikely meaningCaveat
Detectable R. bromiiRS-degrading capacity may be present in the sampled communityStool ≠ guaranteed enrichment in all segments
Low or absentLow habitual RS intake; assay/database miss; recent antibioticsAbsence on 16S is common, not proof the organism is gone
Increase after RS trialConsistent with increased RS substrate in respondersNon-responders exist; gas and bloating can limit dose

Many consumer 16S panels do not include R. bromii in reference databases or collapse it into broader Ruminococcus bins. Shotgun metagenomics improves detection but remains reference-dependent. Compare results only within the same lab and method.

Ruminococcaceae depletion in disease meta-analyses

R. bromii is in Ruminococcaceae (Clostridiales). A meta-reanalysis of 28 case–control studies (Duvallet et al., 2017) found Ruminococcaceae and Lachnospiraceae genera, including butyrate-associated Clostridiales, were consistently depleted in IBD patients relative to controls in multiple studies, and butyrate-producing Clostridia fell in diarrhoeal illness alongside Proteobacteria blooms. Low or absent R. bromii may therefore reflect shared sickness ecology (diarrhoea, inflammation, antibiotics) as much as lack of dietary RS.

That does not negate RS feeding trials, R. bromii remains a plausible keystone for RS2, but a single low readout should not be isolated from other depleted Clostridiales on the same report (Roseburia, Faecalibacterium).

Resistant starch fermentation chain

RS types differ: RS2 (granular, raw sources), RS3 (retrograded, cooled cooked starch), and RS4 (chemically modified) have distinct fermentation kinetics. R. bromii is most studied for RS2; RS3-rich foods (cooled rice, potatoes) still support saccharolytic fermentation but may engage additional taxa.

The ecological story is cross-feeding: R. bromii releases acetate and hydrogen; methanogens and butyrogenic partners consume those substrates (Louis & Flint 2017). A report showing low R. bromii but adequate Roseburia may still support butyrate via other fiber pathways, see dietary fiber breadth, not RS alone.

Low abundance, diet and method context

Populations with low whole-grain and legume intake often show lower R. bromii in observational metagenomes. Antibiotic disruption can suppress keystone degraders for months; recovery is variable. Before treating “missing R. bromii” as pathology, review recent diet, medications, and whether the assay lists the species at all.

The resistant starch intervention page covers dose titration and side effects (gas, bloating). Starting RS because a report flagged low R. bromii is reasonable only when symptoms tolerate fermentable substrate, IBS-D flares may need FODMAP or motility workup first.

What not to conclude

  • That undetected R. bromii means resistant starch will not ferment (other taxa can participate; assay may have missed it).
  • That high R. bromii guarantees high butyrate or symptom improvement.
  • That raw potato starch or any RS supplement is mandatory, whole-food RS sources and mixed fiber are valid paths.
  • That R. bromii readouts diagnose slow transit or constipation without motility assessment (gut motility).